Editas Medicine, INC. (EDIT) SEC Filings — 2025

Filings

• Editas Narrows Losses, Boosts Revenue Amid Restructuring — 10-Q · Nov 10, 2025
• Editas Medicine Files 8-K Report — 8-K · Oct 9, 2025
• Editas Medicine Files 8-K — 8-K · Sep 2, 2025
• Editas Medicine's Restricted Cash Holds Steady at $3,877 — 10-Q · Aug 12, 2025
• Editas Medicine Files 8-K Report — 8-K · Jun 12, 2025
• Editas Medicine Files 8-K with Corporate Updates — 8-K · Jun 2, 2025
• Editas Medicine Files 8-K Report — 8-K · May 14, 2025
• Editas Medicine Files 8-K Report — 8-K · May 13, 2025
• Editas Medicine Files Q1 2025 10-Q — 10-Q · May 12, 2025
• Editas Medicine 2025 Proxy Statement: Executive Pay Details — DEF 14A · Apr 15, 2025
• Editas Medicine Appoints New CFO and Directors — 8-K · Mar 20, 2025
• Editas Medicine, INC. 10-K Filing — 10-K · Mar 5, 2025
• Editas Medicine Files 8-K on Financials — 8-K · Jan 13, 2025